Revenues of leading global generics manufacturers 2022

With a revenue of 8.6 billion U.S. dollars, Teva was the global leading drug manufacturer based on generics revenue in 2022. The second ranked company Sandoz generated some 6.8 billion U.S. dollars that year.

Generic prescription drugs

Worldwide generic prescription drug revenue is expected to increase in the coming years: the total amount of revenue generated in 2022 was estimated at 85 billion U.S. dollars and is projected to reach 100 billion U.S. dollars by 2026. The revenue earned through the global prescribed generics market made up some eight percent of the total prescribed revenue in 2022. Branded prescription medication generally generates the highest revenues: in the U.S., branded drug revenue amounted to some 482 billion U.S. dollars in 2021.

Generic brands

A generic of a brand name drug lacks a widely recognized name. As a result, it tends to make them a cheaper alternative to the brand-name goods, as they are not usually advertised. Interestingly, generic drugs are sometimes created by the same manufacturers that create branded drugs.